GMP Lapses At Biocon’s Indian Site – Jitters for Neulasta Biosimilar Plans?

 
• By Anju Ghangurde
  
Traffic lights
BIOCON'S BANGALORE SITE HAS NOT MADE THE COMPLIANCE CUT YET
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance